Alto Neuroscience ANRO Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $55.94M+19.0% | $45.62M-2.9% | $44.42M-3.1% | $46.96M+15.2% | $47.02M+35.8% | ||
| $21.89M-4.3% | $20.75M-4.0% | $21.88M+24.8% | $23.28M+72.9% | $22.88M+121% | ||
| $77.83M+11.3% | $66.36M-3.3% | $66.31M+4.6% | $70.24M+29.6% | $69.9M+55.4% | ||
| $77.83M+11.3% | $66.36M-3.3% | $66.31M+4.6% | $70.24M+29.6% | $69.9M+55.4% | ||
| -$77.83M-11.3% | -$66.36M+3.3% | -$66.31M-4.6% | -$70.24M-29.6% | -$69.9M-55.4% | ||
| $2.42M+48.5% | $2.47M+79.6% | $2.23M+59.3% | $1.93M+36.4% | $1.63M+16.9% | ||
| $6.34M-30.5% | $6.6M-25.4% | $7.18M-3.7% | $8.15M+43.7% | $9.12M+148% | ||
| $3.52M-47.6% | $3.13M-56.5% | $4.05M-31.7% | $5.38M+22.2% | $6.72M+163% | ||
| $0+100% | -$681K— | -$681K— | -$681K— | -$681K— | ||
| -$74.31M-17.6% | -$63.24M-2.9% | -$62.26M-8.4% | -$64.86M-30.2% | -$63.18M-48.9% | ||
| -$2.42-3.4% | -$2.18+14.2% | -$2.29+53.8% | -$2.39+64.7% | -$2.34+72.5% | ||
| -$2.42-3.4% | -$2.18+14.2% | -$2.29+53.8% | -$2.39+64.7% | -$2.34+72.5% | ||
| 115.9M+9.9% | 110.1M+14.6% | 105.8M+40.7% | 105.7M+103% | 105.5M+267% | ||
| 115.9M+9.9% | 110.1M+14.6% | 105.8M+40.7% | 105.7M+103% | 105.5M+267% | ||
| $26K-80.6% | $153K— | $144K— | $156K— | $134K— | ||
| -$74.31M-17.8% | -$63.12M-2.7% | -$62.15M-8.2% | -$64.74M-30.0% | -$63.09M-48.6% | ||
| -$77.83M-11.3% | -$66.36M+3.3% | -$66.31M-4.6% | -$70.24M-29.6% | -$69.9M-55.4% | ||
| -$77.19M-11.4% | -$65.74M+3.4% | -$65.67M-4.4% | -$69.6M-29.4% | -$69.26M-55.3% | ||
| -$77.19M-11.4% | -$65.74M+3.4% | -$65.67M-4.4% | -$69.6M-29.4% | -$69.26M-55.3% | ||
| -$77.83M-11.3% | -$66.36M+3.3% | -$66.31M-4.6% | -$70.24M-29.6% | -$69.9M-55.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is Alto Neuroscience profitable?
- Alto Neuroscience is not currently profitable: it reported a net loss of $74.3M over the trailing twelve months.
- What is Alto Neuroscience's earnings per share?
- Alto Neuroscience's diluted EPS over the trailing twelve months is $-2.42.
- Where does Alto Neuroscience's income statement data come from?
- Every line is extracted from Alto Neuroscience's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.